Search research articles
Contact Us
Filters
Showing results (31-40 of 110) with videos related to
Page
of 11
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 15, 2020
Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?
Glenda Scandura, Thomas Wagner, Luis Beltran, et al.
Urologic Nursing
|
June 13, 2014
Initial experience of intravesical gemcitabine for patients with high-risk superficial transitional cell carcinoma of the bladder following BCG failure
Paula Allchorne, Benjamin W Lamb, Janette Kinsella, et al.
Oncotargets and Therapy
|
December 4, 2010
The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer
Thomas Powles, Siobhan McFaul, Justin Stebbing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2012
Whole blood stem cell reinfusion and escalated dose melphalan in castration-resistant prostate cancer: a phase 1 study
Jonathan Shamash, Jimmy Jacob, Samir Agrawal, et al.
BJU International
|
June 26, 2010
The application of the National Institute of Clinical Excellence guidelines for treatment of metastatic renal cell carcinoma in the United Kingdom: friend or foe?
Thomas Powles, Rob Jones, Simon Chowdhury, et al.
Oncology and Therapy
|
January 19, 2026
Treatment Strategies in Metastatic Castration-Resistant Prostate Cancer: A Narrative Review of Considerations in the Post-ARTA, Post-Docetaxel Setting
Kenrick Ng, Birth-Lynn Tyers, Aruni Ghose, et al.
Urologia Internationalis
|
December 25, 2017
A Prospective Audit of Intermittent Anti-Androgen verses Pituitary Blockade Suggests a Bipolar Androgen Type Strategy May Be Safe in Untreated Prostate Cancer
Timothy Oliver, Peter Wilson, Wendy Ansell, et al.
British Journal of Haematology
|
April 26, 2017
Intravascular large B-cell lymphoma presenting as a pituitary mass with bilateral adrenal enlargement and haemophagocytic lymphohistiocytosis
Shazia Hussain, Simon Hallam, Luis Beltran, et al.
BJU International
|
July 16, 2020
Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimen
Ernese Gjafa, Kenrick Ng, Tami Grunewald, et al.
Therapeutic Advances in Medical Oncology
|
September 3, 2025
Treatment de-escalation for metastatic good-risk seminoma with carboplatin AUC10: predictive factors and patterns of relapse
Nasreen Abdul Aziz, Didjier Danger Masangwi, Sushila Ganguli, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 110) with videos related to
Sort By:
Page
of 11
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 15, 2020
Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?
Glenda Scandura, Thomas Wagner, Luis Beltran, et al.
Urologic Nursing
|
June 13, 2014
Initial experience of intravesical gemcitabine for patients with high-risk superficial transitional cell carcinoma of the bladder following BCG failure
Paula Allchorne, Benjamin W Lamb, Janette Kinsella, et al.
Oncotargets and Therapy
|
December 4, 2010
The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer
Thomas Powles, Siobhan McFaul, Justin Stebbing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2012
Whole blood stem cell reinfusion and escalated dose melphalan in castration-resistant prostate cancer: a phase 1 study
Jonathan Shamash, Jimmy Jacob, Samir Agrawal, et al.
BJU International
|
June 26, 2010
The application of the National Institute of Clinical Excellence guidelines for treatment of metastatic renal cell carcinoma in the United Kingdom: friend or foe?
Thomas Powles, Rob Jones, Simon Chowdhury, et al.
Oncology and Therapy
|
January 19, 2026
Treatment Strategies in Metastatic Castration-Resistant Prostate Cancer: A Narrative Review of Considerations in the Post-ARTA, Post-Docetaxel Setting
Kenrick Ng, Birth-Lynn Tyers, Aruni Ghose, et al.
Urologia Internationalis
|
December 25, 2017
A Prospective Audit of Intermittent Anti-Androgen verses Pituitary Blockade Suggests a Bipolar Androgen Type Strategy May Be Safe in Untreated Prostate Cancer
Timothy Oliver, Peter Wilson, Wendy Ansell, et al.
British Journal of Haematology
|
April 26, 2017
Intravascular large B-cell lymphoma presenting as a pituitary mass with bilateral adrenal enlargement and haemophagocytic lymphohistiocytosis
Shazia Hussain, Simon Hallam, Luis Beltran, et al.
BJU International
|
July 16, 2020
Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimen
Ernese Gjafa, Kenrick Ng, Tami Grunewald, et al.
Therapeutic Advances in Medical Oncology
|
September 3, 2025
Treatment de-escalation for metastatic good-risk seminoma with carboplatin AUC10: predictive factors and patterns of relapse
Nasreen Abdul Aziz, Didjier Danger Masangwi, Sushila Ganguli, et al.
Page
of 11